BioPorto Logo

BioPorto

An in vitro diagnostics company specializing in biomarkers for early kidney injury detection.

BIOPOR | CO

Overview

Corporate Details

ISIN(s):
DK0011048619
LEI:
5299004SWFL5JAN4W830
Country:
Denmark
Address:
Tuborg Havnevej 15, st., 2900 Hellerup

Description

BioPorto is an in vitro diagnostics company specializing in actionable biomarkers to improve kidney health. The company's primary focus is the development and commercialization of diagnostic tests based on the Neutrophil Gelatinase-Associated Lipocalin (NGAL) biomarker for the early risk assessment and diagnosis of acute kidney injury (AKI). Its product portfolio includes The NGAL Test™ for clinical use and the FDA-cleared ProNephro AKI (NGAL) test for pediatric applications. These tools enable clinicians to detect kidney damage earlier than traditional methods, facilitating timely intervention. BioPorto also provides a range of NGAL ELISA kits and antibodies for preclinical and clinical research settings.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-24 10:37 Danish 34.3 KB
2025-11-24 10:37 English 32.7 KB
2025-11-24 10:37 Danish 566.4 KB
2025-11-24 10:37 English 527.4 KB
2025-11-24 10:09 English 7.4 KB
2025-11-24 10:09 Danish 520.8 KB
2025-11-24 10:09 Danish 7.4 KB
2025-11-24 10:09 English 500.5 KB
2025-11-13 19:50 English 12.3 KB
2025-11-13 19:50 Danish 545.9 KB
2025-11-13 19:50 English 511.2 KB
2025-11-13 19:50 Danish 12.2 KB
2025-11-04 22:10 Danish 225.4 KB
2025-11-04 22:10 English 238.1 KB
2025-11-04 22:10 English 18.9 KB

Automate Your Workflow. Get a real-time feed of all BioPorto filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BioPorto

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BioPorto via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Basilea Pharmaceutica AG Logo
Biopharmaceutical firm developing drugs for severe bacterial and fungal infections.
Switzerland
BSLN
BASKHANBIOPharma Inc. Logo
Offers pharmaceuticals, medical devices, and health products for pain management.
South Korea
354390
Bausch Health Companies Inc. Logo
Develops, manufactures, and markets pharmaceuticals, OTC products, and medical devices.
United States of America
BHC
Bausch & Lomb Corp Logo
Global eye health company offering vision care, pharmaceutical, and surgical products.
United States of America
BLCO
Bavarian Nordic Logo
Biotechnology company developing and commercializing vaccines for infectious diseases.
Denmark
BAVA
BAXTER INTERNATIONAL INC Logo
Provides essential products for renal care, hospital, and surgical settings.
United States of America
BAX
Bayer AG Logo
A global life science company with core competencies in healthcare and nutrition.
Germany
BAY
BBS-Bioactive Bone Substitutes Oyj Logo
Develops and manufactures bioactive medical implants for orthopedic surgery.
Finland
BONE
BCWORLDPHARM Co., Ltd. Logo
Pharmaceutical company specializing in the R&D and manufacturing of prescription drugs.
South Korea
200780
Beam Therapeutics Inc. Logo
Develops precision genetic medicines using proprietary base editing technology.
United States of America
BEAM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.